Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell P Tracy

Showing results (101-110 of 503) with videos related to

Pageof 51
Sort By:
The International Journal of Biochemistry & Cell Biology|November 8, 2005
Soluble interleukin-2 receptor as a marker for progression of coronary artery calcification in type 1 diabetesR Paul Wadwa, Gregory L Kinney, Lorraine Ogden, et al.
The American Journal of Clinical Nutrition|May 31, 2013
Association between circulating vitamin K1 and coronary calcium progression in community-dwelling adults: the Multi-Ethnic Study of AtherosclerosisM Kyla Shea, Sarah L Booth, Michael E Miller, et al.
Metabolomics : Official Journal of the Metabolomic Society|March 5, 2019
A comparison of human serum and plasma metabolites using untargeted <sup>1</sup>H NMR spectroscopy and UPLC-MSManuja Kaluarachchi, Claire L Boulangé, Ibrahim Karaman, et al.
Plos One|October 20, 2012
Angiotensin converting enzyme inhibitor and HMG-CoA reductase inhibitor as adjunct treatment for persons with HIV infection: a feasibility randomized trialJason V Baker, Kathleen Huppler Hullsiek, Rachel Prosser, et al.
BMC Cardiovascular Disorders|March 17, 2011
The contribution of a 9p21.3 variant, a KIF6 variant, and C-reactive protein to predicting risk of myocardial infarction in a prospective studyDov Shiffman, Ellen S O'Meara, Charles M Rowland, et al.
Annals of Human Genetics|January 12, 2010
Interaction between fibrinogen and IL-6 genetic variants and associations with cardiovascular disease risk in the Cardiovascular Health StudyCara L Carty, Patrick Heagerty, Susan R Heckbert, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 29, 2005
Beta-fibrinogen haplotypes and the risk for cardiovascular disease in a dialysis cohortYongmei Liu, Yvette Berthier-Schaad, Nancy E Fink, et al.
Geroscience|August 2, 2023
Associations of plasma NfL, GFAP, and t-tau with cerebral small vessel disease and incident dementia: longitudinal data of the AGES-Reykjavik StudyApril C E van Gennip, Claudia L Satizabal, Russell P Tracy, et al.
The Journal of Infectious Diseases|April 20, 2011
Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapyPeter W Hunt, Jeffrey N Martin, Elizabeth Sinclair, et al.
Obesity (Silver Spring, Md.)|February 25, 2009
A QTL on 12q influencing an inflammation marker and obesity in white women: the NHLBI Family Heart StudyJun Wu, James S Pankow, Russell P Tracy, et al.
Pageof 51

Showing results (101-110 of 503) with videos related to

Sort By:
Pageof 51
The International Journal of Biochemistry & Cell Biology|November 8, 2005
Soluble interleukin-2 receptor as a marker for progression of coronary artery calcification in type 1 diabetesR Paul Wadwa, Gregory L Kinney, Lorraine Ogden, et al.
The American Journal of Clinical Nutrition|May 31, 2013
Association between circulating vitamin K1 and coronary calcium progression in community-dwelling adults: the Multi-Ethnic Study of AtherosclerosisM Kyla Shea, Sarah L Booth, Michael E Miller, et al.
Metabolomics : Official Journal of the Metabolomic Society|March 5, 2019
A comparison of human serum and plasma metabolites using untargeted <sup>1</sup>H NMR spectroscopy and UPLC-MSManuja Kaluarachchi, Claire L Boulangé, Ibrahim Karaman, et al.
Plos One|October 20, 2012
Angiotensin converting enzyme inhibitor and HMG-CoA reductase inhibitor as adjunct treatment for persons with HIV infection: a feasibility randomized trialJason V Baker, Kathleen Huppler Hullsiek, Rachel Prosser, et al.
BMC Cardiovascular Disorders|March 17, 2011
The contribution of a 9p21.3 variant, a KIF6 variant, and C-reactive protein to predicting risk of myocardial infarction in a prospective studyDov Shiffman, Ellen S O'Meara, Charles M Rowland, et al.
Annals of Human Genetics|January 12, 2010
Interaction between fibrinogen and IL-6 genetic variants and associations with cardiovascular disease risk in the Cardiovascular Health StudyCara L Carty, Patrick Heagerty, Susan R Heckbert, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 29, 2005
Beta-fibrinogen haplotypes and the risk for cardiovascular disease in a dialysis cohortYongmei Liu, Yvette Berthier-Schaad, Nancy E Fink, et al.
Geroscience|August 2, 2023
Associations of plasma NfL, GFAP, and t-tau with cerebral small vessel disease and incident dementia: longitudinal data of the AGES-Reykjavik StudyApril C E van Gennip, Claudia L Satizabal, Russell P Tracy, et al.
The Journal of Infectious Diseases|April 20, 2011
Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapyPeter W Hunt, Jeffrey N Martin, Elizabeth Sinclair, et al.
Obesity (Silver Spring, Md.)|February 25, 2009
A QTL on 12q influencing an inflammation marker and obesity in white women: the NHLBI Family Heart StudyJun Wu, James S Pankow, Russell P Tracy, et al.
Pageof 51